PointState Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-291,750
Closed -$12.4M 63
2022
Q2
$12.4M Buy
+291,750
New +$13.9M 0.31% 33
2021
Q3
Sell
-1,459,860
Closed -$95M 161
2021
Q2
$95M Buy
1,459,860
+27,960
+2% +$1.76M 1.64% 21
2021
Q1
$85.2M Buy
1,431,900
+200,300
+16% +$10.9M 1.69% 19
2020
Q4
$58.2M Sell
1,231,600
-513,010
-29% -$21.6M 1.09% 28
2020
Q3
$57.9M Buy
1,744,610
+1,147,100
+192% +$39.5M 1.52% 20
2020
Q2
$19.3M Buy
597,510
+479,510
+406% +$13.1M 0.58% 37
2020
Q1
$2.83M Sell
118,000
-241,000
-67% -$6.94M 0.14% 42
2019
Q4
$10.5M Buy
+359,000
New +$9.53M 0.19% 59
2018
Q3
Sell
-4,559,940
Closed -$78.8M 166
2018
Q2
$78.8M Sell
4,559,940
-14,040,910
-75% -$270M 0.89% 33
2018
Q1
$378M Buy
+18,600,850
New +$368M 4.11% 1

Other funds holding LRCX

PointState Capital's LRCX Position: Q3 2022 in Review

PointState Capital sold out of Lam Research (LRCX) in Q3 2022, closing a stake of 291,750 shares — an estimated $12.4M sold.

PointState Capital first reported a position in LRCX in Q1 2018 and held it in 10 quarters. The position peaked at $378M in Q1 2018. 1,272 funds tracked by Wall St. Rank hold LRCX as of Q3 2022.

  • PointState Capital reported no remaining Lam Research position as of Q3 2022 after selling out during the quarter.
  • PointState Capital sold 291,750 Lam Research shares in Q3 2022, an estimated $12.4M.
  • PointState Capital first reported a position in Lam Research in Q1 2018 and held it in 10 quarters.
  • PointState Capital's Lam Research position peaked at $378M in Q1 2018.
  • 1,272 funds tracked by Wall St. Rank held Lam Research as of Q3 2022.

Based on PointState Capital's 13F filing for Q3 2022, filed 10 Nov 2022.